Use and impact of adjuvant chemotherapy in patients with resected non‐small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|13|1939-1947

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.13, 2014-07, pp. : 1939-1947

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of age on the efficacy of adjuvant chemotherapy for resected non–small cell lung cancer

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2578-2585

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postneoadjuvant adjuvant chemotherapy in resected N1 non‐small cell lung cancer with residual nodal disease

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 116, Iss. 8, 2017-12 ,pp. : 1193-1196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact and Safety of Adjuvant Chemotherapy on Pulmonary Function in Early Stage Non-Small Cell Lung Cancer

By  

Respiration, Vol. 87, Iss. 3, 2013-10 ,pp. : 204-210

Karger

Access to resources Recommend Favorite

Chemotherapy in Non-Small Cell Lung Cancer Patients Receiving Oxygen Therapy

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 587-590

Karger

Access to resources Recommend Favorite

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 92, Iss. 5, 2017-02 ,pp. : 283-290

Karger

Access to resources Recommend Favorite